XML 39 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Quarterly Financial Information (Unaudited) (Tables) - Revision of Prior Period, Adjustment [Member]
12 Months Ended
Dec. 31, 2023
Quarterly Financial Information (Unaudited) (Tables) [Line Items]  
Schedule of Condensed Consolidated Balance Sheets Incorporated herein is expanded disclosure of the restatements of the quarterly information for the three months ended March 30, 2023, three and six-months ended June 30, 2023, and three and nine-months ended September 30, 2023.
   AS RESTATED 
   3/31/2023   6/30/2023   9/30/2023 
Assets            
Cash and cash equivalents   97,811    20,880    92,722 
Prepaid expense   102,980    52,885    27,550 
Total current assets   200,791    73,765    120,272 
                
Investments held in Trust Account   54,368,297    55,154,617    35,096,667 
Total Assets   54,569,088    55,228,382    35,216,939 
                
Liabilities, Redeemable Ordinary Shares and Stockholders’ Deficit               
Accounts payable and accounts payable   3,584,797    3,853,954    3,976,694 
Due to related party   265,000    331,826    258,966 
Convertible promissory note -related party   1,000,000    1,000,000    1,000,000 
Promissory Note - related party   250,000    250,000    250,000 
Subscription liability, net of debt discount   251,880    467,274    1,060,112 
Forward Purchase Agreement liability   633,205    -    - 
Total current liabilities   5,984,882    5,903,054    6,545,772 
                
Warrant liability   2,401,703    423,458    758,433 
Total liabilities   8,386,585    6,326,512    7,304,205 
                
Commitments and Contingencies   
 
    
 
    
 
 
Class A Common Stock subject to possible redemption, 5,228,218, 5,228,218 and 3,255,593 shares at $10.40, $10.55 and $10.78 redemption value as of March 31, 2023, June 30, 2023 and September 30, 2023, respectively   54,368,296    55,154,617    35,096,667 
                
Stockholders’ Deficit:               
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding   -    -    - 
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 0, 0 and 799 shares issued and outstanding (excluding 5,228,218, 5,228,218 and 3,255,593 shares subject to possible redemption) as of March 31, 2023, June 30, 2023 and September 30, 2023, respectively.   -    -    799 
 Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 7,980,409, 7,980,409 and 0 shares issued and outstanding as of March 31, 2023, June 30, 2023 and September 30, 2023.   799    799    - 
Additional paid-in capital   7,531,767    6,912,413    6,319,277 
Accumulated deficit   (15,718,359)   (13,165,959)   (13,504,009)
Total stockholders’ deficit   (8,185,793)   (6,252,747)   (7,183,933)
                
Total Liabilities, Redeemable Ordinary Shares and Stockholders’ Deficit   54,569,088    55,228,382    35,216,939 

 

Schedule of Condensed Consolidated Statements of Operations
   AS RESTATED 
   For the three months ended
March 31, 2023
   For the three months ended
June 30,
2023
   For the six months ended
June 30,
2023
   For the three months ended
September 30,
2023
   For the nine months ended
September 30,
2023
 
                     
Formation and operating costs  $1,153,282   $578,954   $1,732,236   $353,372   $2,085,609 
Loss from operations   (1,153,282)   (578,954)   (1,732,236)   (353,372)   (2,085,609)
                          
Other (expense) income:                         
Change in fair value of warrants liabilities   (2,022,486)   1,978,245    (44,241)   (334,975)   (379,216)
Change in fair value of Forward Purchase Agreement   (325,091)   633,205    308,114    -    308,114 
Issuance of Forward Purchase Agreement   (308,114)   -    (308,114)   -    (308,114)
Reduction of deferred underwriter fee payable   328,474    -    328,474    -    328,474 
Interest Expense – Debt Discount   (28,515)   (106,416)   (134,931)   (279,013)   (413,944)
Interest income – trust account   3,088,967    626,320    3,715,287    629,310    4,344,597 
Total other (expense) income, net   733,235    3,131,354    3,864,589    15,322    3,879,911 
                          
Net (loss) income  $(420,047)  $2,552,400   $2,132,353   $(338,050)  $1,794,302 
                          
Weighted average shares outstanding, Class A ordinary shares subject to possible redemption   26,286,357    13,208,627    15,699,116    4,970,919    12,083,753 
Basic and diluted net income per ordinary share, Class A ordinary shares subject to possible redemption  $(0.01)  $0.12   $0.09   $(0.03)  $0.09 
Weighted average shares outstanding, Class A ordinary shares subject to possible redemption   

-

    

-

    

-

    1,474,641    526,181 
Basic and diluted net income per ordinary share, Class A ordinary shares   

-

    

-

    

-

   $(0.03)  $0.09 
Weighted average shares outstanding, Class B ordinary shares   7,980,409    7,980,409    7,980,409    6,505,768    7,454,228 
Basic and diluted net income per ordinary share, Class B ordinary shares  $(0.01)  $0.12   $0.09   $(0.03)  $0.09 

 

Schedule of Condensed Consolidated Statements of Changes in Shareholders’ Deficit
   Class A ordinary shares   Class B ordinary shares   Additional
Paid-in
   Accumulated   Shareholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit   Deficit 
Balance as of December 31, 2022   -   $-    7,980,409   $799   $-   $(15,298,312)  $(15,297,513)
Reduction of deferred underwriter fees                       10,844,098         10,844,098 
Accretion of Class A ordinary shares to redemption value                       (3,568,966)   -    (3,568,966)
Issuance of subscription shares                       256,635         256,635 
Net loss                            (420,047)   (420,047)
Balance as of March 31, 2023 (As Restated)   -   $-    7,980,409   $799   $7,531,767   $(15,718,359)  $(8,185,793)
Accretion of Class A ordinary shares to redemption value                       (786,320)   -    (786,320)
Issuance of subscription shares                       166,966         166,966 
Net Income                            2,552,400    2,552,400 
Balance as of June 30, 2023 (As Restated)   -   $-    7,980,409   $799   $6,912,413   $(13,165,959)  $(6,252,747)
Conversion of class B shares to Class A shares   7,980,409    799    (7,980,409)   (799)             - 
Accretion of Class A ordinary shares to redemption value                       (1,084,311)   -    (1,084,311)
Issuance of subscription shares                       491,175         491,175 
Net loss                            (338,050)   (338,050)
Balance as of September 30, 2023 (As Restated)   7,980,409   $799    -   $-   $6,319,277   $(13,504,009)  $(7,183,933)

 

Schedule of Condensed Consolidated Statements of Cash Flows
   AS RESTATED 
   For the three
months ended
March 31,
2023
   For the six months ended
June 30,
2023
   For the nine
months ended
September 30,
2023
 
Cash flows from Operating Activities:            
Net (loss) income  $(420,048)  $2,132,353   $1,794,302 
Adjustments to reconcile net loss to net cash used in operating activities:               
Interest earned on cash held in Trust Account   (3,088,966)   (3,715,287)   (4,344,597)
Reduction of deferred underwriter fees   (328,474)   (328,474)   (328,474)
Changes in fair value of warrant liabilities   2,022,486    44,241    379,216 
Issuance of FPA   308,114    308,114    308,114 
Change in fair value of FPA   325,091    (308,114)   (308,114)
Interest expense - debt discount   28,515    134,931    413,944 
                
Prepaid assets   (59,349)   (9,254)   16,081 
Due to related party   30,000    96,826    23,966 
Accounts payable and accrued expenses   944,041    1,213,199    1,335,939 
Net cash used in operating activities   (238,590)   (431,465)   (709,623)
                
Cash flows from Investing Activities:               
Extension payment deposit in Trust   (480,000)   (640,000)   (1,095,000)
Cash withdrawn for redemptions   273,112,312    273,112,312    294,254,572 
Net cash used in investing activities   272,632,312    272,472,312    293,159,572 
                
Cash flows from Financing Activities:               
Redemption of ordinary shares   (273,112,312)   (273,112,312)   (294,254,572)
Proceeds from note payable-related party   250,000    250,000    250,000 
Proceeds from subscription liability   480,000    755,944    1,560,944 
Net cash provided by financing activities   (272,382,312)   (272,106,368)   (292,443,628)
                
Net Change in Cash   11,410    (65,521)   6,321 
Cash, Beginning of period   86,401    86,401    86,401 
Cash, End of period  $97,811   $20,880   $92,722 
Non-Cash investing and financing activities:            
Accretion of Class A ordinary shares subject to possible redemption  $3,568,966   $4,355,287   $5,439,596 
Issuance of Subscription Shares  $256,635   $423,601   $914,776